Bowman Bagley - 18 Mar 2026 Form 3 Insider Report for CollPlant Biotechnologies Ltd (CLGN)

Role
VP Commercial North America
Signature
/s/ Bowman Bagley
Issuer symbol
CLGN
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 10:18:28 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bagley Bowman VP Commercial North America C/O COLLPLANT BIOTECHNOLOGIES LTD., 4 OPPENHEIMER ST, WEIZMANN SCIENCE PARK, REHOVOT, ISRAEL /s/ Bowman Bagley 18 Mar 2026 0002117210

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLGN Restricted Share Units 25,000 18 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted share units shall vest over a period of 4 years as follows: 25% shall vest on January 1, 2027, and the remaining 75% shall vest in twelve equal quarterly installments thereafter.